EDA and X-linked hypohidrotic ectodermal dysplasia: In both mouse and dog models of XLHED, ER004 was found to correct many of the phenotypic features of EDA1 deficiency if administered prenatally or very soon after birth, leading to a sustained health improvement [17,18,19,20,21].